Hirofumi Michimae

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

Noriyuki Katsumata, Makoto Yasuda, Seiji Isonishi et al. · The Lancet Oncology · 2013 · 481 citations

Medicine, Gynecology, Oncology +13

A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial

Kaoru Kubota, Hiroshi Sakai, Nobuyuki Katakami et al. · Annals of Oncology · 2015 · 89 citations · Full text

Medicine, Oncology, Pharmacology +9

Applicability of the concept of “platinum sensitivity” to recurrent endometrial cancer: The SGSG-012/GOTIC-004/Intergroup study

Shoji Nagao, Shin Nishio, Hirofumi Michimae et al. · Gynecologic Oncology · 2013 · 78 citations

Medicine, Gynecology, Oncology +6

A TADPOLE-INDUCED POLYPHENISM IN THE SALAMANDER HYNOBIUS RETARDATUS

Hirofumi Michimae, Masami Wakahara · Evolution · 2002 · 72 citations

Life Sciences, Biology, Zoology +17

Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial Cancer at a High Risk of Progression

Hiroyuki Nomura, Daisuke Aoki, Hirofumi Michimae et al. · JAMA Oncology · 2019 · 66 citations · Full text

Medicine, Gynecology, Oncology +14